Lasofoxifene in postmenopausal women with osteoporosis.

Publication Type:

Journal Article

Authors:

Cummings, Steven R; Ensrud, Kristine; Delmas, Pierre D; LaCroix, Andrea Z; Vukicevic, Slobodan; Reid, David M; Goldstein, Steven; Sriram, Usha; Lee, Andy; Thompson, John; Armstrong, Roisin A; Thompson, David D; Powles, Trevor; Zanchetta, Jose; Kendler, David; Neven, Patrick; Eastell, Richard

Source:

The New England journal of medicine, Volume 362, Issue 8, p.686-96 (2010)

Keywords:

2010, Aged, Bone Density, Bone Density Conservation Agents, Breast Neoplasms, Center-Authored Paper, Coronary Disease, Female, Fractures, Bone, Humans, Middle Aged, Osteoporosis, Postmenopausal, Public Health Sciences Division, Pyrrolidines, Receptors, Estrogen, RISK, Selective Estrogen Receptor Modulators, Spinal Fractures, Stroke, Tetrahydronaphthalenes, Venous Thromboembolism

Abstract:

The effects of lasofoxifene on the risk of fractures, breast cancer, and cardiovascular disease are uncertain.

Doing Business with Arnold Library

Weintraub Building, B1-010
(206) 667-4314
library@fredhutch.org

More About Arnold Library

OFF-CAMPUS LOGIN

Quick Links